A series of 5-(2- or 3-thienyl)tryptamine derivatives (9) has been synthesi
zed and shown to be potent and selective 5-HT1D versus 5-HT1B receptor agon
ists and, therefore, potential treatments for migraine. (C) 2000 Elsevier S
cience Ltd. All rights reserved.